Elimination of trachoma: knowing where to intervene

Summary

This editorial describes how increased attention and funding from major donors, like the Department for International Development (DFID) and the United States Agency for International Development (USAID), combined with continued commitment from Pfizer for the donation of Zithromax has put trachoma on track for elimination.

Attention is drawn to six articles in this issue of Ophthalmic Epidemiology (Vol. 23, Issue 6) that are an outcome of the Global Trachoma Mapping Project and additional articles anticipated in a forthcoming supplementary issue of Ophthalmic Epidemiology (Vol, 25 sup1). The authors conclude that trachoma elimination is no longer aspirational; it is attainable.